Hitz and colleagues observed enhanced levels of CHOP and IRE1α in PBMCs of lenalidomide-refractory MM patients receiving combination therapy of nelfinavir, lenalidomide, and dexamethasone [76]. Here, ERN1 is linked to Miyoshi myopathy.